Plasma leptin levels vary with the periods during chemotherapy [2]

American Journal of Hematology

Volumn 74, Issue 2, 2003, Pages 145-

  Minami, Rumi ^a   Muta, Koichiro ^a   Ilseung, Choi ^a   Matsushima, Takamitsu ^a   Abe, Yasunobu ^a   Nishimura, Junji ^b   Nawata, Hajime ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; BLOOD LEVEL; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CELL DIFFERENTIATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LETTER; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0141730291     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10397     Document Type: Letter

References (5)

1. Bennett BD, Solar GP, Yuan JQ, Mathias J, Thomas GR, Matthews W. A role for leptin and its cognate receptor in hematopoiesis. Curr Biol 1996;6:1170-1180.
2. Hirose H, Saito I, Kawai T, Nakamura K, Maruyama H, Saruta T. Serum leptin level: possible association with haematopoiesis in adolescents, independent of body mass index and serum insulin. Clin Sci 1998;94:633-636.
3. Huang XJ, Wan J, Lu DP. Serum TNFalpha levels in patients with acute graft-versus-host disease after bone marrow transplantation. Leukemia 2001;15:1089-1091.
4. Hill GR, Teshima T, Gerbitz A, et al. Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia J Clin Invest 1999;104:459-467.
5. Laharrague P, Larrouy D, Fontanilles AM, et al. High expression of leptin by human bone marrow adipocytes in primary culture. FASEB J 1998;12:747-752.